<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Neurol</journal-id><journal-id journal-id-type="iso-abbrev">Front Neurol</journal-id><journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id><journal-title-group><journal-title>Frontiers in Neurology</journal-title></journal-title-group><issn pub-type="epub">1664-2295</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40401030</article-id><article-id pub-id-type="pmc">PMC12092221</article-id><article-id pub-id-type="doi">10.3389/fneur.2025.1466188</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neurology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Predicting early functional outcomes in aneurysmal subarachnoid hemorrhage in endovascular coiling and surgical clipping</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chu</surname><given-names>Liang</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2794642/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Cao</surname><given-names>Kan</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Kuan</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author"><name><surname>Lu</surname><given-names>Yunpeng</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Qi</surname><given-names>Ming</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wu</surname><given-names>Da</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>The Affiliated Yixing Hospital of Jiangsu University</institution>, <addr-line>Yixing</addr-line>, <country>China</country></aff><aff id="aff2"><sup>2</sup><institution>The Affiliated Zhenjiang First Hospital of Jiangsu University</institution>, <addr-line>Zhenjiang</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by" id="fn0001"><p>Edited by: Stefano Maria Priola, Health Sciences North, Canada</p></fn><fn fn-type="edited-by" id="fn0002"><p>Reviewed by: Qazi Zeeshan, University of Pittsburgh Medical Center, United States</p><p>Taisuke Akimoto, Yokohama City University, Japan</p><p>Tijana Nastasovic, University of Belgrade, Serbia</p></fn><corresp id="c001">*Correspondence: Da Wu, <email>wudabrain@163.com</email></corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>16</volume><elocation-id>1466188</elocation-id><history><date date-type="received"><day>18</day><month>7</month><year>2024</year></date><date date-type="accepted"><day>22</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Chu, Cao, Jiang, Lu, Qi and Wu.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Chu, Cao, Jiang, Lu, Qi and Wu</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><sec id="sec1"><title>Objectives</title><p>This study aimed to evaluate early functional outcomes in patients with aneurysmal subarachnoid hemorrhage (aSAH) treated with either endovascular coiling or surgical clipping and to develop predictive models tailored to each treatment modality.</p></sec><sec id="sec2"><title>Materials and methods</title><p>Patients diagnosed with aSAH were retrospectively enrolled from two hospitals in China between January 1, 2015, and December 31, 2022. Based on the treatment approach, patients were divided into two groups: endovascular coiling and surgical clipping. Independent risk factors were identified using least absolute shrinkage and selection operator (LASSO) regression followed by multivariate logistic regression. The relative contribution of each significant factor was calculated, and nomograms were constructed accordingly. Model performance was subsequently assessed through validation analyses.</p></sec><sec id="sec3"><title>Results</title><p>Multivariate analysis identified Hunt&#x02013;Hess grade, Glasgow Coma Scale (GCS) score, modified Fisher Scale (mFS), D-dimer, age, and body temperature as independent predictors of early functional outcomes following endovascular coiling (all <italic>p</italic>-values &#x0003c;0.05). For surgical clipping, Hunt&#x02013;Hess grade, GCS score, mFS, and D-dimer emerged as significant predictors (all <italic>p</italic>-values &#x0003c;0.05). The calculated relative contributions for endovascular coiling were 32.78% (Hunt&#x02013;Hess grade), 31.99% (mFS), 4.63% (GCS score), and 13.73% (D-dimer); for surgical clipping, these values were 33.55, 38.02, 8.44, and 19.99%, respectively. Nomograms were developed for both treatment groups, and their performance was validated using receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA), demonstrating strong discriminative ability and clinical applicability.</p></sec><sec id="sec4"><title>Conclusion</title><p>This study developed predictive nomogram models for early functional outcomes of aSAH patients undergoing endovascular coiling or surgical clipping treatments, emphasizing the importance of scoring systems and clinical parameters (such as D-dimer), demonstrating strong clinical utility.</p></sec></abstract><kwd-group><kwd>aneurysmal subarachnoid hemorrhage</kwd><kwd>early functional outcomes</kwd><kwd>endovascular coiling</kwd><kwd>surgical clipping</kwd><kwd>D-dimer</kwd><kwd>nomogram</kwd></kwd-group><funding-group><award-group><funding-source id="cn1">Key Project of the Medical-Educational Collaborative Innovation Fund</funding-source><award-id award-type="contract" rid="cn1">JDY2023011</award-id></award-group><funding-statement>The author(s) declare that financial support was received for the research and/or publication of this article. This study was supported by the Key Project of the Medical-Educational Collaborative Innovation Fund at Jiangsu University for the year 2023 (Project No. JDY2023011).</funding-statement></funding-group><counts><fig-count count="7"/><table-count count="5"/><equation-count count="0"/><ref-count count="31"/><page-count count="13"/><word-count count="5609"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Endovascular and Interventional Neurology</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec5"><title>Introduction</title><p>Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening cerebrovascular disorder with significant global morbidity and mortality. The global incidence of aSAH is approximately 6.1 cases per 100,000 person-years (<xref rid="ref1" ref-type="bibr">1</xref>), while in China, it is estimated at around 2.0 cases per 100,000 person-years (<xref rid="ref2" ref-type="bibr">2</xref>). Notably, epidemiological studies have established a positive correlation between aSAH incidence and advancing age (<xref rid="ref3" ref-type="bibr">3</xref>). As populations worldwide age, the number of individuals at risk of aSAH is expected to rise, underscoring the urgent need for effective diagnostic and treatment strategies.</p><p>For patients with ruptured aneurysms in anterior or posterior circulations, endovascular coiling generally yields better short-term outcomes compared to surgical clipping (<xref rid="ref4" ref-type="bibr">4</xref>, <xref rid="ref5" ref-type="bibr">5</xref>). However, surgical clipping remains the preferred approach for patients with large intracerebral hematomas or middle cerebral artery aneurysms due to its unique advantages (<xref rid="ref6" ref-type="bibr">6</xref>). Findings from the International Subarachnoid Aneurysm Trial (ISAT) (<xref rid="ref7" ref-type="bibr">7</xref>) showed that the endovascular coiling group had a 7% lower 1-year mortality rate than the surgical clipping group, albeit with an increased long-term risk of rebleeding.</p><p>Current clinical evaluations of postoperative outcomes after surgical clipping and endovascular coiling predominantly rely on the Hunt&#x02013;Hess grading scale and the Glasgow Coma Scale (GCS). While valuable, these traditional assessment tools do not comprehensively account for individualized clinical parameters that may significantly influence patient prognosis (<xref rid="ref8" ref-type="bibr">8</xref>). This study aimed to develop novel nomogram models based on commonly used clinical scoring systems and selected clinical parameters to assess early functional outcomes&#x02014;such as neurological recovery and activities of daily living&#x02014;in patients undergoing the two different surgical approaches.</p></sec><sec sec-type="materials|methods" id="sec6"><title>Materials and methods</title><sec id="sec7"><title>Study population</title><p>This study retrospectively and continuously collected patients with aSAH who were hospitalized and treated at the Affiliated Yixing Hospital of Jiangsu University and the Affiliated Zhenjiang First Hospital of Jiangsu University from 1st January, 2015 to 31st December, 2022. Diagnosis, surgery, and perioperative management strictly adhered to the latest clinical practice guidelines of the Chinese Medical Association (<xref rid="ref9" ref-type="bibr">9</xref>). The surgical approach for each case was determined by a neurosurgical team of senior neurosurgeons, based on individual patient characteristics, aneurysm features, and in accordance with available clinical guidelines. When both surgical options were deemed feasible, the final decision was made through team consensus, taking into account the preferences of the patient&#x02019;s family or designated surrogate decision-maker. Postoperatively, patients typically required intensive care management, which followed guideline-based protocols and included close monitoring, appropriate sedation and analgesia, cardiovascular support, vasospasm prevention, and active management of potential complications. The study adhered to the Helsinki Declaration and obtained approval from the ethics committees of two hospitals, with approval numbers 2023043 and K-20230086-w. All participants or their authorized representatives were required to sign an informed consent form during hospitalization, ensuring their full understanding of the purpose, methods, risks, and benefits of the surgery and study, and indicating their voluntary participation.</p><p>Inclusion criteria include: (1) age 18&#x0202f;years or older; (2) confirmed as aSAH through laboratory and imaging examinations; (3) patients must undergo either endovascular coiling or surgical clipping treatment. Exclusion criteria include: (1) previous hospitalization for aSAH; (2) subarachnoid hemorrhage caused by other reasons, including vascular malformation, cerebral atherosclerosis, trauma, etc.; (3) the presence of severe cardiovascular, liver, kidney or other vital organ diseases; (4) loss of clinical parameters such as platelet count and D-dimer.</p></sec><sec id="sec8"><title>The study variables and outcomes</title><p>The study variables include demographic information (age and sex), physical examination data (body temperature and mean arterial pressure), laboratory tests (D-dimer, and platelet count), imaging examinations (length, width, height, position, etc.), past medical history (hypertension and diabetes), clinical scoring tools (GCS, Hunt&#x02013;Hess, and mFS), treatment modalities (endovascular coiling and surgical clipping), and the use of stents. Patients were stratified into the endovascular coiling group and the surgical clipping group based on treatment methods.</p><p>The primary endpoint of this study was the early functional outcomes of patients 1&#x0202f;month after surgery. Considering that the modified Rankin Scale (mRS) is recommended for assessing neurological recovery status, this study utilized the mRS score at 1&#x0202f;month post-surgery as the primary endpoint, with scores ranging from 0 to 3 indicating a favorable prognosis and scores from 4 to 6 indicating an unfavorable prognosis (<xref rid="ref10" ref-type="bibr">10</xref>).</p></sec><sec id="sec9"><title>Statistical analysis</title><p>Chi-square tests were used for categorical variables, while non-parametric tests were employed for continuous variables. Univariate and multivariate logistic regression analyses were conducted to determine independent predictive factors and calculate their relative weights on the outcome variable. Two separate nomogram models were developed to predict early functional outcomes in aSAH patients undergoing endovascular coiling and Surgical clipping, respectively. Receiver operating characteristic curves (ROC) were plotted, and the area under the curve (AUC) was calculated to assess the discriminative ability of the nomogram. Calibration curves were generated to illustrate the consistency between predicted probabilities and observed outcomes across various predicted probabilities. Decision curve analysis (DCA) was conducted to evaluate the clinical utility of the nomogram. Finally, risk stratification was performed. All statistical analyses were conducted using SPSS version 26.0 and R version 4.3.1, with statistical significance defined at the conventional threshold of <italic>p</italic>&#x0202f;&#x0003c;&#x0202f;0.05 (two-tailed).</p></sec></sec><sec sec-type="results" id="sec10"><title>Results</title><sec id="sec11"><title>Characteristics of patients in the endovascular coiling and surgical clipping groups</title><p>A total of 962 patients diagnosed with aSAH were included in the final analysis cohort (<xref rid="fig1" ref-type="fig">Figure 1</xref>). Overall, the proportion of early adverse outcomes in the surgical clipping group (32.7%) was higher than that in the endovascular coiling group (15.0%) (<xref rid="fig2" ref-type="fig">Figure 2</xref>). In patients undergoing endovascular coiling, those with poor functional outcomes tended to be older, have higher D-dimer levels, higher Hunt&#x02013;Hess grades, GCS scores of 3&#x02013;8, higher mFS grades, larger aneurysm volumes, were more likely to be located in the anterior cerebral artery and posterior circulation. Among patients undergoing surgical clipping, those with poor functional outcomes tended to be older, have higher Hunt&#x02013;Hess grades, GCS scores of 3&#x02013;8, higher mFS grades, higher D-dimer levels, and lower platelet counts (<xref rid="tab1" ref-type="table">Tables 1</xref>, <xref rid="tab2" ref-type="table">2</xref>).</p><fig position="float" id="fig1"><label>Figure 1</label><caption><p>Flow diagram of eligible patients diagnosed with aSAH.</p></caption><graphic xlink:href="fneur-16-1466188-g001" position="float"/></fig><fig position="float" id="fig2"><label>Figure 2</label><caption><p><bold>(A)</bold> Ruptured aneurysm of the left middle cerebral artery with subarachnoid hemorrhage. <bold>(B)</bold> DSA showing left middle cerebral artery aneurysm. <bold>(C)</bold> Post-embolization CT of left middle cerebral artery aneurysm. <bold>(D)</bold> Post-embolization angiogram of left middle cerebral artery aneurysm. <bold>(E)</bold> Left cerebral middle artery aneurysm rupture with subarachnoid hemorrhage and temporal lobe hematoma. <bold>(F)</bold> Left cerebral middle artery aneurysm CTA imaging. <bold>(G)</bold> Post-clipping of left cerebral middle artery aneurysm and clearance of temporal lobe hematoma. <bold>(H)</bold> Post-clipping of left cerebral middle artery aneurysm.</p></caption><graphic xlink:href="fneur-16-1466188-g002" position="float"/></fig><table-wrap position="float" id="tab1"><label>Table 1</label><caption><p>Baseline characteristics of patients undergoing endovascular coiling.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Variables</th><th align="center" valign="top" rowspan="1" colspan="1">Total (<italic>n</italic> =&#x0202f;638)</th><th align="center" valign="top" rowspan="1" colspan="1">Good functional outcome (<italic>n</italic> =&#x0202f;542)</th><th align="center" valign="top" rowspan="1" colspan="1">Poor functional outcome (<italic>n</italic> =&#x0202f;96)</th><th align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>-value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Age, years</td><td align="center" valign="middle" rowspan="1" colspan="1">60.0 (52.0&#x02013;68.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">60.0 (51.8&#x02013;67.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">64.0 (53.0&#x02013;72.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gender</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.703</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Female</td><td align="center" valign="middle" rowspan="1" colspan="1">413 (64.7%)</td><td align="center" valign="middle" rowspan="1" colspan="1">353 (65.1%)</td><td align="center" valign="middle" rowspan="1" colspan="1">60 (62.5%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" rowspan="1" colspan="1">225 (35.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">189 (34.9%)</td><td align="center" valign="middle" rowspan="1" colspan="1">36 (37.5%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hunt&#x02013;Hess grade</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">0&#x02013;3</td><td align="center" valign="middle" rowspan="1" colspan="1">566 (88.7%)</td><td align="center" valign="middle" rowspan="1" colspan="1">514 (94.8%)</td><td align="center" valign="middle" rowspan="1" colspan="1">52 (54.2%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">4&#x02013;5</td><td align="center" valign="middle" rowspan="1" colspan="1">72 (11.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">28 (5.2%)</td><td align="center" valign="middle" rowspan="1" colspan="1">44 (45.8%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hypertension</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.809</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="middle" rowspan="1" colspan="1">263 (41.2%)</td><td align="center" valign="middle" rowspan="1" colspan="1">225 (41.5%)</td><td align="center" valign="middle" rowspan="1" colspan="1">38 (39.6%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">375 (58.8%)</td><td align="center" valign="middle" rowspan="1" colspan="1">317 (58.5%)</td><td align="center" valign="middle" rowspan="1" colspan="1">58 (60.4%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Diabetes mellitus</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.293</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="middle" rowspan="1" colspan="1">597 (93.6%)</td><td align="center" valign="middle" rowspan="1" colspan="1">510 (94.1%)</td><td align="center" valign="middle" rowspan="1" colspan="1">87 (90.6%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">41 (6.4%)</td><td align="center" valign="middle" rowspan="1" colspan="1">32 (5.9%)</td><td align="center" valign="middle" rowspan="1" colspan="1">9 (9.4%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Body temperature, &#x000b0;C</td><td align="center" valign="middle" rowspan="1" colspan="1">36.8 (36.5&#x02013;37.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">36.8 (36.5&#x02013;37.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">36.8 (36.3&#x02013;37.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.068</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MAP, mmHg</td><td align="center" valign="middle" rowspan="1" colspan="1">106.67 (96.67&#x02013;117.33%)</td><td align="center" valign="middle" rowspan="1" colspan="1">106.67 (96.67&#x02013;116.67%)</td><td align="center" valign="middle" rowspan="1" colspan="1">108.67 (98.67%&#x02013;124.00%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.105</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GCS score</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3&#x02013;8</td><td align="center" valign="middle" rowspan="1" colspan="1">61 (9.6%)</td><td align="center" valign="middle" rowspan="1" colspan="1">19 (3.5%)</td><td align="center" valign="middle" rowspan="1" colspan="1">42 (43.8%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">9&#x02013;12</td><td align="center" valign="middle" rowspan="1" colspan="1">50 (7.8%)</td><td align="center" valign="middle" rowspan="1" colspan="1">35 (6.5%)</td><td align="center" valign="middle" rowspan="1" colspan="1">15 (15.6%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">12&#x02013;15</td><td align="center" valign="middle" rowspan="1" colspan="1">527 (82.6%)</td><td align="center" valign="middle" rowspan="1" colspan="1">488 (90.0%)</td><td align="center" valign="middle" rowspan="1" colspan="1">39 (40.6%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">mFS</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">0&#x02013;2</td><td align="center" valign="middle" rowspan="1" colspan="1">245 (38.4%)</td><td align="center" valign="middle" rowspan="1" colspan="1">234 (43.2%)</td><td align="center" valign="middle" rowspan="1" colspan="1">11 (11.5%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3&#x02013;4</td><td align="center" valign="middle" rowspan="1" colspan="1">393 (61.6%)</td><td align="center" valign="middle" rowspan="1" colspan="1">308 (56.8%)</td><td align="center" valign="middle" rowspan="1" colspan="1">85 (88.5%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Length, mm</td><td align="center" valign="middle" rowspan="1" colspan="1">4.0 (3.00&#x02013;6.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.0 (3.00&#x02013;6.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.58 (3.00&#x02013;7.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.063</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Width, mm</td><td align="center" valign="middle" rowspan="1" colspan="1">4.0 (3.00&#x02013;5.21)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.0 (3.00&#x02013;5.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.5 (3.00&#x02013;6.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.191</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Height, mm</td><td align="center" valign="middle" rowspan="1" colspan="1">4.0 (3.00&#x02013;5.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.88 (2.80&#x02013;5.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.00 (3.00&#x02013;6.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.038</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Volume, mm<sup>3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">33.51 (14.22&#x02013;66.76)</td><td align="center" valign="middle" rowspan="1" colspan="1">31.42 (14.14&#x02013;65.45)</td><td align="center" valign="middle" rowspan="1" colspan="1">41.89 (18.43&#x02013;89.54)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.027</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Aneurysm location</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.018</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Anterior cerebral artery</td><td align="center" valign="middle" rowspan="1" colspan="1">190 (29.8%)</td><td align="center" valign="middle" rowspan="1" colspan="1">154 (28.4%)</td><td align="center" valign="middle" rowspan="1" colspan="1">36 (37.5%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Middle cerebral artery</td><td align="center" valign="middle" rowspan="1" colspan="1">53 (8.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">49 (9.0%)</td><td align="center" valign="middle" rowspan="1" colspan="1">4 (4.2%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Internal carotid artery</td><td align="center" valign="middle" rowspan="1" colspan="1">135 (21.2%)</td><td align="center" valign="middle" rowspan="1" colspan="1">121 (22.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">14 (14.6%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Posterior communicating artery</td><td align="center" valign="middle" rowspan="1" colspan="1">200 (31.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">173 (31.9%)</td><td align="center" valign="middle" rowspan="1" colspan="1">27 (28.1%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Posterior circulation</td><td align="center" valign="middle" rowspan="1" colspan="1">60 (9.4%)</td><td align="center" valign="middle" rowspan="1" colspan="1">45 (8.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">15 (15.6%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Presence of hematoma</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.375</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="middle" rowspan="1" colspan="1">628 (98.4%)</td><td align="center" valign="middle" rowspan="1" colspan="1">535 (98.7%)</td><td align="center" valign="middle" rowspan="1" colspan="1">93 (96.9%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">10 (1.6%)</td><td align="center" valign="middle" rowspan="1" colspan="1">7 (1.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">3 (3.1%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Use of stents</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.724</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="middle" rowspan="1" colspan="1">325 (50.9%)</td><td align="center" valign="middle" rowspan="1" colspan="1">274 (50.6%)</td><td align="center" valign="middle" rowspan="1" colspan="1">51 (53.1%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">313 (49.1%)</td><td align="center" valign="middle" rowspan="1" colspan="1">268 (49.4%)</td><td align="center" valign="middle" rowspan="1" colspan="1">45 (46.9%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">D-dimer, mg/L</td><td align="center" valign="middle" rowspan="1" colspan="1">0.81 (0.40&#x02013;1.85)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.72 (0.33&#x02013;1.54)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.86 (0.94&#x02013;4.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PLT, &#x000d7;10<sup>9</sup>/L</td><td align="center" valign="middle" rowspan="1" colspan="1">208.0 (169.25&#x02013;261.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">207.5 (170.25&#x02013;260.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">211.50 (158.25&#x02013;267.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.858</td></tr></tbody></table><table-wrap-foot><p>MAP, mean arterial pressure; GCS, Glasgow Coma Scale; PLT, platelet.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="tab2"><label>Table 2</label><caption><p>Baseline characteristics of patients undergoing neurosurgical clipping.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Variables</th><th align="center" valign="top" rowspan="1" colspan="1">Total (<italic>n</italic> =&#x0202f;324)</th><th align="center" valign="top" rowspan="1" colspan="1">Good functional outcome (<italic>n</italic> =&#x0202f;218)</th><th align="center" valign="top" rowspan="1" colspan="1">Poor functional outcome (<italic>n</italic> =&#x0202f;106)</th><th align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>-value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Age, years</td><td align="center" valign="middle" rowspan="1" colspan="1">60.0 (51.75&#x02013;68.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">58.5 (51.00&#x02013;67.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">63.0 (53.25&#x02013;69.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.020</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gender</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.720</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Female</td><td align="center" valign="middle" rowspan="1" colspan="1">208 (64.2%)</td><td align="center" valign="middle" rowspan="1" colspan="1">138 (63.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">70 (66.0%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" rowspan="1" colspan="1">116 (35.8%)</td><td align="center" valign="middle" rowspan="1" colspan="1">80 (36.7%)</td><td align="center" valign="middle" rowspan="1" colspan="1">36 (34.0%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hunt&#x02013;Hess grade</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">0&#x02013;3</td><td align="center" valign="middle" rowspan="1" colspan="1">200 (61.7%)</td><td align="center" valign="middle" rowspan="1" colspan="1">167 (76.6%)</td><td align="center" valign="middle" rowspan="1" colspan="1">33 (31.1.2%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">4&#x02013;5</td><td align="center" valign="middle" rowspan="1" colspan="1">124 (38.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">51 (23.4%)</td><td align="center" valign="middle" rowspan="1" colspan="1">73 (68.9%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hypertension</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="middle" rowspan="1" colspan="1">91 (28.1%)</td><td align="center" valign="middle" rowspan="1" colspan="1">61 (28.0%)</td><td align="center" valign="middle" rowspan="1" colspan="1">30 (28.3%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">233 (71.9%)</td><td align="center" valign="middle" rowspan="1" colspan="1">157 (72.0%)</td><td align="center" valign="middle" rowspan="1" colspan="1">76 (71.7%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Diabetes mellitus</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="middle" rowspan="1" colspan="1">308 (95.1%)</td><td align="center" valign="middle" rowspan="1" colspan="1">207 (95.0%)</td><td align="center" valign="middle" rowspan="1" colspan="1">101 (95.3%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">16 (4.9%)</td><td align="center" valign="middle" rowspan="1" colspan="1">11 (5.0%)</td><td align="center" valign="middle" rowspan="1" colspan="1">5 (4.7%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Body temperature, &#x000b0;C</td><td align="center" valign="middle" rowspan="1" colspan="1">36.80 (36.5&#x02013;37.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">36.80 (36.5&#x02013;37.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">36.80 (36.5&#x02013;37.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.975</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MAP, mmHg</td><td align="center" valign="middle" rowspan="1" colspan="1">111.00 (98.67&#x02013;122.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">111.00 (98.75&#x02013;123.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">111.50 (97.75&#x02013;120.67)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.741</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GCS score</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3&#x02013;8</td><td align="center" valign="middle" rowspan="1" colspan="1">95 (29.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">34 (15.6%)</td><td align="center" valign="middle" rowspan="1" colspan="1">61 (57.5%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">9&#x02013;12</td><td align="center" valign="middle" rowspan="1" colspan="1">23 (7.1%)</td><td align="center" valign="middle" rowspan="1" colspan="1">17 (7.8%)</td><td align="center" valign="middle" rowspan="1" colspan="1">6 (5.7%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">12&#x02013;15</td><td align="center" valign="middle" rowspan="1" colspan="1">206 (63.6%)</td><td align="center" valign="middle" rowspan="1" colspan="1">167 (76.6%)</td><td align="center" valign="middle" rowspan="1" colspan="1">39 (36.8%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">mFS</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">0&#x02013;2</td><td align="center" valign="middle" rowspan="1" colspan="1">136 (42.0%)</td><td align="center" valign="middle" rowspan="1" colspan="1">121 (55.5%)</td><td align="center" valign="middle" rowspan="1" colspan="1">15 (14.2%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3&#x02013;4</td><td align="center" valign="middle" rowspan="1" colspan="1">188 (58.0%)</td><td align="center" valign="middle" rowspan="1" colspan="1">97 (44.5%)</td><td align="center" valign="middle" rowspan="1" colspan="1">91 (85.8%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Length, mm</td><td align="center" valign="middle" rowspan="1" colspan="1">4.00 (3.00&#x02013;6.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.00 (3.00&#x02013;5.20)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.00 (3.00&#x02013;6.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.651</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Width, mm</td><td align="center" valign="middle" rowspan="1" colspan="1">4.00 (3.00&#x02013;5.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.00 (3.00&#x02013;5.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.00 (3.00&#x02013;5.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.088</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Height, mm</td><td align="center" valign="middle" rowspan="1" colspan="1">4.00 (3.00&#x02013;5.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.00 (3.00&#x02013;5.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.00 (3.00&#x02013;5.00)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.093</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Aneurysm volume, mm<sup>3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">33.51 (14.14&#x02013;65.45)</td><td align="center" valign="middle" rowspan="1" colspan="1">31.42 (14.14&#x02013;62.83)</td><td align="center" valign="middle" rowspan="1" colspan="1">33.51 (14.14&#x02013;89.54)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.186</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Aneurysm location</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.231</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Anterior cerebral artery</td><td align="center" valign="middle" rowspan="1" colspan="1">106 (32.7%)</td><td align="center" valign="middle" rowspan="1" colspan="1">75 (34.4%)</td><td align="center" valign="middle" rowspan="1" colspan="1">31 (29.2%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Middle cerebral artery</td><td align="center" valign="middle" rowspan="1" colspan="1">126 (38.9%)</td><td align="center" valign="middle" rowspan="1" colspan="1">81 (37.2%)</td><td align="center" valign="middle" rowspan="1" colspan="1">45 (42.5%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Internal carotid artery</td><td align="center" valign="middle" rowspan="1" colspan="1">40 (12.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">26 (11.9%)</td><td align="center" valign="middle" rowspan="1" colspan="1">14 (13.2%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Posterior communicating artery</td><td align="center" valign="middle" rowspan="1" colspan="1">44 (13.6%)</td><td align="center" valign="middle" rowspan="1" colspan="1">33 (15.1%)</td><td align="center" valign="middle" rowspan="1" colspan="1">11 (10.4%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Posterior circulation</td><td align="center" valign="middle" rowspan="1" colspan="1">8 (2.5%)</td><td align="center" valign="middle" rowspan="1" colspan="1">3 (1.4%)</td><td align="center" valign="middle" rowspan="1" colspan="1">5 (4.7%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Presence of hematoma</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">0.791</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">No</td><td align="center" valign="middle" rowspan="1" colspan="1">276 (85.2%)</td><td align="center" valign="middle" rowspan="1" colspan="1">187 (85.8%)</td><td align="center" valign="middle" rowspan="1" colspan="1">89 (84.0%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">48 (14.8%)</td><td align="center" valign="middle" rowspan="1" colspan="1">31 (14.2%)</td><td align="center" valign="middle" rowspan="1" colspan="1">17 (16.0%)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">D-dimer, mg/L</td><td align="center" valign="middle" rowspan="1" colspan="1">1.64 (0.73&#x02013;2.93)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.33 (0.66&#x02013;2.48)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.33 (1.34&#x02013;3.99)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PLT, &#x000d7;10<sup>9</sup>/L</td><td align="center" valign="middle" rowspan="1" colspan="1">260.00 (160.75&#x02013;349.25)</td><td align="center" valign="middle" rowspan="1" colspan="1">286.00 (192.75&#x02013;362.50)</td><td align="center" valign="middle" rowspan="1" colspan="1">194.50 (119.25&#x02013;291.75)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><p>MAP, mean arterial pressure; GCS, Glasgow Coma Scale; PLT, platelet.</p></table-wrap-foot></table-wrap></sec><sec id="sec12"><title>Univariate and multivariate logistic regression analysis</title><p>We utilized univariate and multivariate logistic regression models to assess the impact of clinical variables and scores on outcomes. The results revealed that, in the endovascular coiling group, age [adjusted odds ratio (OR): 1.033, 95% confidence interval (CI): 1.007&#x02013;1.06, <italic>p</italic>&#x0202f;=&#x0202f;0.015], Hunt&#x02013;Hess grade (adjusted OR: 2.727, 95% CI: 1.172&#x02013;6.154, <italic>p</italic>&#x0202f;=&#x0202f;0.017), GCS score (9&#x02013;12: adjusted OR: 0.308, 95% CI: 0.11&#x02013;0.835, <italic>p</italic>&#x0202f;=&#x0202f;0.022; 12&#x02013;15: adjusted OR: 0.098, 95% CI: 0.039&#x02013;0.24, <italic>p</italic>&#x0202f;&#x0003c;&#x0202f;0.001), mFS (adjusted OR: 2.769, 95% CI: 1.382&#x02013;5.959, <italic>p</italic>&#x0202f;=&#x0202f;0.006), D-dimer (adjusted OR: 1.248, 95% CI: 1.106&#x02013;1.412, <italic>p</italic>&#x0202f;&#x0003c;&#x0202f;0.001), and body temperature (adjusted OR: 0.469, 95% CI: 0.274&#x02013;0.784, <italic>p</italic>&#x0202f;=&#x0202f;0.005) were significantly associated with early adverse functional outcomes (<xref rid="tab3" ref-type="table">Table 3</xref>). Whereas, in the surgical clipping group, Hunt&#x02013;Hess grade (adjusted OR: 2.369, 95% CI: 1.051&#x02013;5.408, <italic>p</italic>&#x0202f;=&#x0202f;0.038), GCS score (12&#x02013;15: adjusted OR: 0.274, 95% CI: 0.121&#x02013;0.606, <italic>p</italic>&#x0202f;=&#x0202f;0.002), mFS (adjusted OR: 2.918, 95% CI:1.245&#x02013;6.994, <italic>p</italic>&#x0202f;=&#x0202f;0.014), and D-dimer (adjusted OR: 1.508, 95% CI: 1.304&#x02013;1.766, <italic>p</italic>&#x0202f;&#x0003c;&#x0202f;0.001) were independent predictors of early functional outcomes (<xref rid="tab4" ref-type="table">Table 4</xref>). The forest plot displays the significant multivariable factors (<xref rid="fig3" ref-type="fig">Figures 3A</xref>,<xref rid="fig3" ref-type="fig">B</xref>).</p><table-wrap position="float" id="tab3"><label>Table 3</label><caption><p>Logistic analysis of early functional outcomes after endovascular coiling.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="2" colspan="1">Variables</th><th align="center" valign="top" colspan="2" rowspan="1">Univariable<xref rid="tfn1" ref-type="table-fn"><sup>a</sup></xref></th><th align="center" valign="top" colspan="2" rowspan="1">Multivariable<xref rid="tfn2" ref-type="table-fn"><sup>b</sup></xref></th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1">OR (95% CI)</th><th align="center" valign="top" rowspan="1" colspan="1"><italic>p-</italic>value</th><th align="center" valign="top" rowspan="1" colspan="1">OR (95% CI)</th><th align="center" valign="top" rowspan="1" colspan="1"><italic>p-</italic>value</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sex</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" rowspan="1" colspan="1">1.121 (0.71&#x02013;1.748)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.619</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age</td><td align="center" valign="middle" rowspan="1" colspan="1">1.031 (1.01&#x02013;1.053)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.004</td><td align="center" valign="middle" rowspan="1" colspan="1">1.033 (1.007&#x02013;1.06)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.015</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hunt&#x02013;Hess</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0&#x02013;3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">4&#x02013;5</td><td align="center" valign="middle" rowspan="1" colspan="1">15.533 (9.002&#x02013;27.292)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">2.727 (1.172&#x02013;6.154)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.017</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Body temperature</td><td align="center" valign="middle" rowspan="1" colspan="1">0.613 (0.379&#x02013;0.979)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.043</td><td align="center" valign="middle" rowspan="1" colspan="1">0.469 (0.274&#x02013;0.784)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.005</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GCS</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">3&#x02013;8</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">9&#x02013;12</td><td align="center" valign="middle" rowspan="1" colspan="1">0.194 (0.084&#x02013;0.429)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.308 (0.11&#x02013;0.835)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.022</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">12&#x02013;15</td><td align="center" valign="middle" rowspan="1" colspan="1">0.036 (0.019&#x02013;0.067)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.098 (0.039&#x02013;0.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">PLT</td><td align="center" valign="middle" rowspan="1" colspan="1">0.999 (0.996&#x02013;1.002)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.574</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">D-dimer</td><td align="center" valign="middle" rowspan="1" colspan="1">1.375 (1.248&#x02013;1.522)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">1.248 (1.106&#x02013;1.412)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">mFS</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">0&#x02013;2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">3&#x02013;4</td><td align="center" valign="middle" rowspan="1" colspan="1">5.871 (3.193&#x02013;11.875)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">2.769 (1.382&#x02013;5.959)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hypertension</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">1.083 (0.698&#x02013;1.698)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.723</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Diabetes</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">1.649 (0.719&#x02013;3.44)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.205</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Length</td><td align="center" valign="middle" rowspan="1" colspan="1">1.032 (0.976&#x02013;1.086)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.239</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Width</td><td align="center" valign="middle" rowspan="1" colspan="1">1.018 (0.952&#x02013;1.08)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.565</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Height</td><td align="center" valign="middle" rowspan="1" colspan="1">1.044 (0.966&#x02013;1.12)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.252</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Volume</td><td align="center" valign="middle" rowspan="1" colspan="1">1 (0.999&#x02013;1)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.985</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MAP</td><td align="center" valign="middle" rowspan="1" colspan="1">1.014 (1.001&#x02013;1.027)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.028</td><td align="center" valign="middle" rowspan="1" colspan="1">1.015 (1.000&#x02013;1.031)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.051</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Stent</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">0.902 (0.583&#x02013;1.393)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.642</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Aneurysm location</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Anterior cerebral artery</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Middle cerebral artery</td><td align="center" valign="middle" rowspan="1" colspan="1">0.349 (0.101&#x02013;0.928)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.057</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Internal carotid artery</td><td align="center" valign="middle" rowspan="1" colspan="1">0.495 (0.248&#x02013;0.94)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.037</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Posterior communicating artery</td><td align="center" valign="middle" rowspan="1" colspan="1">0.668 (0.385&#x02013;1.147)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.146</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Posterior circulation</td><td align="center" valign="middle" rowspan="1" colspan="1">1.426 (0.702&#x02013;2.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.312</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tfn1"><label>a</label><p>Univariable logistic regression models.</p></fn><fn id="tfn2"><label>b</label><p>Multivariable logistic regression model adjusting for age at diagnosis Hunt&#x02013;Hess grade, body temperature, MAP, GCS score, and D-dimer.</p></fn><p>OR, odd ratio; CI, confidence interval; MAP, mean arterial pressure; GCS, Glasgow Coma Scale.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="tab4"><label>Table 4</label><caption><p>Logistic analysis of early functional outcomes after surgical clipping.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="2" colspan="1">Variables</th><th align="center" valign="top" colspan="2" rowspan="1">Univariable<xref rid="tfn3" ref-type="table-fn"><sup>a</sup></xref></th><th align="center" valign="top" colspan="2" rowspan="1">Multivariable<xref rid="tfn4" ref-type="table-fn"><sup>b</sup></xref></th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1">OR (95% CI)</th><th align="center" valign="top" rowspan="1" colspan="1"><italic>p-</italic>value</th><th align="center" valign="top" rowspan="1" colspan="1">OR (95% CI)</th><th align="center" valign="top" rowspan="1" colspan="1"><italic>p-</italic>value</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sex</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" rowspan="1" colspan="1">0.887 (0.542&#x02013;1.439)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.630</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age</td><td align="center" valign="middle" rowspan="1" colspan="1">1.026 (1.003&#x02013;1.049)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.027</td><td align="center" valign="middle" rowspan="1" colspan="1">1.021 (0.994&#x02013;1.05)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.128</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hunt&#x02013;Hess</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0&#x02013;3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">4&#x02013;5</td><td align="center" valign="middle" rowspan="1" colspan="1">7.244 (4.358&#x02013;12.281)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">2.369 (1.051&#x02013;5.408)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.038</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Body temperature</td><td align="center" valign="middle" rowspan="1" colspan="1">1.025 (0.644&#x02013;1.613)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.916</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GCS</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">3&#x02013;8</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">9&#x02013;12</td><td align="center" valign="middle" rowspan="1" colspan="1">0.197 (0.066&#x02013;0.522)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" rowspan="1" colspan="1">0.376 (0.111&#x02013;1.173)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.099</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">12&#x02013;15</td><td align="center" valign="middle" rowspan="1" colspan="1">0.13 (0.075&#x02013;0.223)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.274 (0.121&#x02013;0.606)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">PLT</td><td align="center" valign="middle" rowspan="1" colspan="1">0.997 (0.995&#x02013;0.999)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">0.998 (0.996&#x02013;1.000)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.060</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">D-dimer</td><td align="center" valign="middle" rowspan="1" colspan="1">1.266 (1.132&#x02013;1.423)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">1.508 (1.304&#x02013;1.766)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">mFS</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">0&#x02013;2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">3&#x02013;4</td><td align="center" valign="middle" rowspan="1" colspan="1">7.568 (4.228&#x02013;14.364)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">2.918 (1.245&#x02013;6.994)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.014</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hypertension</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">0.984 (0.591&#x02013;1.662)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.952</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Diabetes</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">0.932 (0.287&#x02013;2.635)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.898</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Length</td><td align="center" valign="middle" rowspan="1" colspan="1">1.058 (0.994&#x02013;1.128)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.076</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Width</td><td align="center" valign="middle" rowspan="1" colspan="1">1.064 (0.991&#x02013;1.151)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.095</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Height</td><td align="center" valign="middle" rowspan="1" colspan="1">1.09 (1.004&#x02013;1.197)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.049</td><td align="center" valign="middle" rowspan="1" colspan="1">1.057 (0.958&#x02013;1.178)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.283</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Volume</td><td align="center" valign="middle" rowspan="1" colspan="1">1 (1.000&#x02013;1.001)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.284</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MAP</td><td align="center" valign="middle" rowspan="1" colspan="1">0.994 (0.981&#x02013;1.007)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.360</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Aneurysm volume</td><td align="center" valign="middle" rowspan="1" colspan="1">1 (1&#x02013;1.001)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.284</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Anterior cerebral artery</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Middle cerebral artery</td><td align="center" valign="middle" rowspan="1" colspan="1">1.344 (0.774&#x02013;2.354)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.296</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Internal carotid artery</td><td align="center" valign="middle" rowspan="1" colspan="1">1.303 (0.592&#x02013;2.801)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.502</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Posterior communicating artery</td><td align="center" valign="middle" rowspan="1" colspan="1">0.806 (0.351&#x02013;1.761)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.598</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Posterior circulation</td><td align="center" valign="middle" rowspan="1" colspan="1">4.032 (0.933&#x02013;20.641)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.067</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tfn3"><label>a</label><p>Univariable logistic regression models.</p></fn><fn id="tfn4"><label>b</label><p>Multivariable logistic regression model adjusting for age at diagnosis, blood group, GCS score, aneurysm width, aneurysm height, D-dimer, and PLT.</p></fn><p>OR, odd ratio; CI, confidence interval; MAP, mean arterial pressure; GCS, Glasgow Coma Scale.</p></table-wrap-foot></table-wrap><fig position="float" id="fig3"><label>Figure 3</label><caption><p>Forest plot based on multivariate analysis in the endovascular coiling <bold>(A)</bold> and surgical clipping groups <bold>(B)</bold>.</p></caption><graphic xlink:href="fneur-16-1466188-g003" position="float"/></fig></sec><sec id="sec13"><title>The relative weights of impact on the early functional outcome</title><p>We further assessed the relative impact of significant variables on early functional outcomes using multivariate logistic regression analysis. In the endovascular coiling group, the proportions of significant variables were as follows: Hunt&#x02013;Hess grade contributed 32.78%, mFS contributed 31.99%, D-dimer contributed 13.73%, age contributed 11.61%, body temperature contributed 5.26%, and GCS contributed 4.63%. In the surgical clipping group, mFS contributed 38.02%, Hunt&#x02013;Hess grade contributed 33.55%, D-dimer contributed 19.99%, and GCS contributed 8.44% (<xref rid="fig4" ref-type="fig">Figures 4A</xref>,<xref rid="fig4" ref-type="fig">B</xref>).</p><fig position="float" id="fig4"><label>Figure 4</label><caption><p>The relative weights of variables influencing early functional outcomes in the endovascular coiling <bold>(A)</bold> and surgical clipping groups <bold>(B)</bold>.</p></caption><graphic xlink:href="fneur-16-1466188-g004" position="float"/></fig></sec><sec id="sec14"><title>Nomogram for early functional outcome and validation</title><p>Nomogram models were developed for different groups based on early functional outcomes (<xref rid="fig5" ref-type="fig">Figures 5A</xref>, <xref rid="fig6" ref-type="fig">6A</xref>). In the endovascular coiling group, the ROC curve indicated good predictive accuracy, with an AUC value of 0.847 (95% CI: 0.800&#x02013;0.894) (<xref rid="fig5" ref-type="fig">Figure 5B</xref>), and the calibration curve demonstrated close alignment between the model and predictions (<xref rid="fig5" ref-type="fig">Figure 5C</xref>). The decision curve analysis (DCA) curve showed good clinical predictive value across different threshold probabilities (<xref rid="fig5" ref-type="fig">Figure 5D</xref>). Similarly, in the surgical clipping group, the ROC curve showed good predictive accuracy, with an AUC value of 0.841 (95% CI: 0.796&#x02013;0.886) (<xref rid="fig6" ref-type="fig">Figure 6B</xref>), and the calibration curve exhibited basic alignment with predictions (<xref rid="fig6" ref-type="fig">Figure 6C</xref>). The DCA curve also demonstrated good clinical predictive value across different threshold probabilities (<xref rid="fig6" ref-type="fig">Figure 6D</xref>). In addition, by incorporating the surgical approach as an additional variable into the shared predictive factors, we developed a new, integrated nomogram model (<xref rid="fig7" ref-type="fig">Figure 7A</xref>). This model achieved an AUC of 0.857 for predicting poor outcomes within 1&#x0202f;month (<xref rid="fig7" ref-type="fig">Figure 7B</xref>). The calibration curve demonstrated good agreement between predicted and observed outcomes, and the DCA showed favorable clinical utility across a range of threshold probabilities (<xref rid="fig7" ref-type="fig">Figures 7C</xref>,<xref rid="fig7" ref-type="fig">D</xref>).</p><fig position="float" id="fig5"><label>Figure 5</label><caption><p>Constructing a nomogram <bold>(A)</bold> to forecast functional outcomes in patients undergoing endovascular coiling, and validating it through ROC curves <bold>(B)</bold>, calibration plots <bold>(C)</bold>, and DCA curves <bold>(D)</bold>.</p></caption><graphic xlink:href="fneur-16-1466188-g005" position="float"/></fig><fig position="float" id="fig6"><label>Figure 6</label><caption><p>Constructing a nomogram <bold>(A)</bold> to forecast functional outcomes in patients undergoing surgical clipping, and validating it through ROC curves <bold>(B)</bold>, calibration plots <bold>(C)</bold>, and DCA curves <bold>(D)</bold>.</p></caption><graphic xlink:href="fneur-16-1466188-g006" position="float"/></fig><fig position="float" id="fig7"><label>Figure 7</label><caption><p>Constructing an integrated nomogram <bold>(A)</bold> to forecast functional outcomes of aSAH patients after surgery, and validating it through ROC curves <bold>(B)</bold>, calibration plots <bold>(C)</bold>, and DCA curves <bold>(D)</bold>.</p></caption><graphic xlink:href="fneur-16-1466188-g007" position="float"/></fig></sec><sec id="sec15"><title>Nomogram-based risk stratification predicts early functional outcome</title><p>Based on the risk scores predicted by the nomogram, patients were categorized into three groups: low risk, medium risk, and high risk. In the endovascular coiling group, individuals in the medium-risk group faced a 2.791-fold higher risk compared to those in the low-risk category, while those in the high-risk group experienced a significantly elevated risk of 17.506 times compared to the low-risk group (<xref rid="tab5" ref-type="table">Table 5</xref>). Similarly, within the surgical clipping group, participants classified in the medium-risk tier were at a 5.291-fold increased risk relative to the low-risk counterparts, with those in the high-risk category encountering an even greater risk, elevated by a substantial 26.641 times compared to the low-risk group (<xref rid="tab5" ref-type="table">Table 5</xref>). These differences were statistically significant, highlighting the clinical significance of our nomogram model in integrating clinical scores and parameters.</p><table-wrap position="float" id="tab5"><label>Table 5</label><caption><p>Nomogram risk stratification.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="2" colspan="1">Variables</th><th align="center" valign="top" colspan="2" rowspan="1">Endovascular coiling</th><th align="center" valign="top" colspan="2" rowspan="1">Surgical clipping</th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1">OR (95% CI)</th><th align="center" valign="top" rowspan="1" colspan="1"><italic>p-</italic>value</th><th align="center" valign="top" rowspan="1" colspan="1">OR (95% CI)</th><th align="center" valign="top" rowspan="1" colspan="1"><italic>p-</italic>value</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Low-risk group</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Medium-risk group</td><td align="center" valign="middle" rowspan="1" colspan="1">2.791 (1.134, 7.868)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.034</td><td align="center" valign="middle" rowspan="1" colspan="1">5.291 (2.326, 13.671)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">High-risk group</td><td align="center" valign="middle" rowspan="1" colspan="1">17.506 (8.014, 46.109)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">26.641 (11.913, 68.537)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table></table-wrap></sec></sec><sec sec-type="discussion" id="sec16"><title>Discussion</title><p>Despite significant advancements in managing patients with subarachnoid hemorrhage, the mortality rate remains high. The case-fatality rate for aSAH ranges from 32 to 67%, with approximately one-third of survivors experiencing long-term disability or cognitive impairment (<xref rid="ref11" ref-type="bibr">11</xref>). Numerous studies have identified risk factors that influence the onset and progression of aSAH, including sex, hypertension, alcohol consumption, and smoking (<xref rid="ref12" ref-type="bibr">12&#x02013;14</xref>), as well as aneurysm-related factors such as size and location (<xref rid="ref15" ref-type="bibr">15&#x02013;17</xref>), influence the occurrence and development of aSAH. In addition, proteomic analyses have revealed that proteins involved in the focal adhesion and extracellular matrix&#x02013;receptor interaction pathways may play a key role in the pathogenesis of intracranial aneurysms (<xref rid="ref18" ref-type="bibr">18</xref>). Currently, endovascular coiling and neurosurgical clipping have become the main treatment methods for aSAH.</p><p>In our study, the incidence of early adverse functional outcomes was significantly lower in patients undergoing endovascular coiling compared to those treated with neurosurgical clipping, which is consistent with current clinical guidelines (<xref rid="ref19" ref-type="bibr">19</xref>, <xref rid="ref20" ref-type="bibr">20</xref>). However, endovascular coiling is associated with increased hospitalization costs (<xref rid="ref21" ref-type="bibr">21</xref>), and carries certain risks, including a lower rate of complete aneurysm occlusion and a higher risk of delayed rebleeding (<xref rid="ref22" ref-type="bibr">22&#x02013;24</xref>). Based on this, we have established two new nomogram models, which were based on commonly used clinical scoring systems (such as the Hunt&#x02013;Hess grading scale and the GCS) and some clinical parameters, to evaluate the early functional outcomes of these two different surgical methods. Each variable corresponds to a score on the top line of the nomogram. The total score, calculated by summing the scores of all variables, is projected onto the bottom scale to estimate the probability of early postoperative poor outcomes in patients with aSAH (<xref rid="ref25" ref-type="bibr">25</xref>). Moreover, our results indicate that the prognostic models for both surgical approaches demonstrate good discriminatory power and calibration. Therefore, this tool has the potential to assist neurosurgeons in clinical decision-making and enhance the effective communication of prognostic information to patients&#x02019; families. In addition, based on the shared independent predictors identified from the two models, we further developed an integrated nomogram incorporating the surgical approach as a covariate. This comprehensive model also demonstrated favorable predictive performance, supporting its potential utility in clinical practice for holistic risk stratification and management planning.</p><p>This study found that among patients treated with endovascular coiling, those who exhibited poorer early functional outcomes typically had older age, higher mFS scores, higher Hunt&#x02013;Hess grades, and lower GCS scores, consistent with prior research (<xref rid="ref26" ref-type="bibr">26</xref>, <xref rid="ref27" ref-type="bibr">27</xref>). Additionally, we observed that these patients often presented with elevated D-dimer levels, larger aneurysm sizes, and anterior cerebral artery location of the aneurysm. In patients undergoing surgical clipping, factors influencing early functional outcomes typically included Hunt&#x02013;Hess and mFS scores, which align with findings from Li&#x02019;s et al. (<xref rid="ref21" ref-type="bibr">21</xref>) study. Furthermore, our study indicated that lower GCS scores, elevated D-dimer levels, and decreased platelet counts were predictive of poorer early functional outcomes. Our results highlight the different perioperative priorities associated with each surgical modality. For high-risk patients undergoing endovascular treatment, enhanced monitoring for thromboembolic events and proactive temperature management may be warranted. Surgical candidates with elevated D-dimer levels may benefit from preoperative optimization of hemostasis and postoperative antifibrinolytic therapy.</p><p>Through multifactorial logistic analysis, age, body temperature, D-dimer, mFS score, Hunt&#x02013;Hess grade, and GCS score were identified as independent risk factors for early functional outcomes in the endovascular coiling group. For surgical clipping treatment, Hunt&#x02013;Hess grade, GCS score, mFS, and D-dimer level were determined as independent risk factors influencing early functional outcomes. Of note, the relative contribution analysis revealed that Hunt&#x02013;Hess grade and mFS were the dominant predictors in both models, while D-dimer ranked among the top three contributors in each group, further supporting its clinical relevance. Interestingly, D-dimer levels can predict outcomes in both surgical methods, possibly because: (1) in neurosurgical procedures, stress may affect patients&#x02019; hemostatic and fibrinolytic functions; (2) changes in D-dimer levels can reflect alterations in coagulation status, and abnormal D-dimer levels may indicate postoperative bleeding and thrombotic complications (<xref rid="ref28" ref-type="bibr">28&#x02013;30</xref>). Additionally, hypothermia may lead to poorer outcomes in patients undergoing endovascular coiling treatment, possibly due to its adverse effects on resuscitation and potential myocardial damage (<xref rid="ref31" ref-type="bibr">31</xref>). For the first time, we have identified that D-dimer levels significantly influence early functional outcomes in patients treated with either endovascular coiling or surgical clipping. This finding place D-dimer levels second only to Hunt&#x02013;Hess grading and the mFS scoring system, surpassing GCS scores in importance. Moreover, the inclusion of D-dimer challenges traditional reliance on clinical grading scales alone. Implementing these models could improve resource allocation by identifying patients who may derive greater benefit from intensive care or targeted interventions.</p><p>The study has some limitations. Firstly, being a retrospective study, there may be confounding factors affecting the stability of the results. Secondly, the assessment of early functional outcomes was conducted only one-month post-surgery, requiring further long-term follow-up to evaluate more comprehensive outcomes. Thirdly, we did not include emerging biomarkers or advanced imaging features, which could potentially enhance predictive accuracy. Therefore, prospective studies with longer follow-up periods are needed to validate these findings and explore intervention strategies based on these risk profiles.</p></sec></body><back><sec sec-type="data-availability" id="sec17"><title>Data availability statement</title><p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p></sec><sec sec-type="ethics-statement" id="sec18"><title>Ethics statement</title><p>The studies involving humans were approved by the Affiliated Yixing Hospital of Jiangsu University (2023043) and the Affiliated Zhenjiang First Hospital of Jiangsu University (K-20230086-w). The studies were conducted in accordance with the local legislation and institutional requirements. The ethics committee/institutional review board waived the requirement of written informed consent for participation from the participants or the participants&#x02019; legal guardians/next of kin because informed consent was waived by both committees due to the retrospective nature of the study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p></sec><sec sec-type="author-contributions" id="sec19"><title>Author contributions</title><p>LC: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. KC: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Writing &#x02013; original draft. KJ: Conceptualization, Formal analysis, Investigation, Project administration, Resources, Validation, Writing &#x02013; original draft. YL: Data curation, Investigation, Methodology, Resources, Software, Writing &#x02013; review &#x00026; editing. MQ: Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Validation, Writing &#x02013; original draft. DW: Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing.</p></sec><sec sec-type="COI-statement" id="sec21"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="sec22"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="ref1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etminan</surname><given-names>N</given-names></name><name><surname>Chang</surname><given-names>HS</given-names></name><name><surname>Hackenberg</surname><given-names>K</given-names></name><name><surname>de Rooij</surname><given-names>NK</given-names></name><name><surname>Vergouwen</surname><given-names>MDI</given-names></name><name><surname>Rinkel</surname><given-names>GJE</given-names></name><etal/></person-group>. <article-title>Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis</article-title>. <source>JAMA Neurol</source>. (<year>2019</year>) <volume>76</volume>:<fpage>588</fpage>&#x02013;<lpage>97</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamaneurol.2019.0006</pub-id>, PMID: <pub-id pub-id-type="pmid">30659573</pub-id>
</mixed-citation></ref><ref id="ref2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingall</surname><given-names>T</given-names></name><name><surname>Asplund</surname><given-names>K</given-names></name><name><surname>M&#x000e4;h&#x000f6;nen</surname><given-names>M</given-names></name><name><surname>Bonita</surname><given-names>R</given-names></name></person-group>. <article-title>A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study</article-title>. <source>Stroke</source>. (<year>2000</year>) <volume>31</volume>:<fpage>1054</fpage>&#x02013;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.1161/01.STR.31.5.1054</pub-id>, PMID: <pub-id pub-id-type="pmid">10797165</pub-id>
</mixed-citation></ref><ref id="ref3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakker</surname><given-names>MK</given-names></name><name><surname>Kanning</surname><given-names>JP</given-names></name><name><surname>Abraham</surname><given-names>G</given-names></name><name><surname>Martinsen</surname><given-names>AE</given-names></name><name><surname>Winsvold</surname><given-names>BS</given-names></name><name><surname>Zwart</surname><given-names>JA</given-names></name><etal/></person-group>. <article-title>Genetic risk score for intracranial aneurysms: prediction of subarachnoid hemorrhage and role in clinical heterogeneity</article-title>. <source>Stroke</source>. (<year>2023</year>) <volume>54</volume>:<fpage>810</fpage>&#x02013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.122.040715</pub-id>, PMID: <pub-id pub-id-type="pmid">36655558</pub-id>
</mixed-citation></ref><ref id="ref4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name></person-group>. <article-title>Treatment of intracranial aneurysms: clipping versus coiling</article-title>. <source>Curr Cardiol Rep</source>. (<year>2015</year>) <volume>17</volume>:<fpage>628</fpage>. doi: <pub-id pub-id-type="doi">10.1007/s11886-015-0628-2</pub-id>, PMID: <pub-id pub-id-type="pmid">26238743</pub-id>
</mixed-citation></ref><ref id="ref5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindgren</surname><given-names>A</given-names></name><name><surname>Vergouwen</surname><given-names>MD</given-names></name><name><surname>van der Schaaf</surname><given-names>I</given-names></name><name><surname>Algra</surname><given-names>A</given-names></name><name><surname>Wermer</surname><given-names>M</given-names></name><name><surname>Clarke</surname><given-names>MJ</given-names></name><etal/></person-group>. <article-title>Endovascular coiling versus neurosurgical clipping for people with aneurysmal subarachnoid haemorrhage</article-title>. <source>Cochrane Database Syst Rev</source>. (<year>2018</year>) <volume>2018</volume>:<fpage>CD003085</fpage>. doi: <pub-id pub-id-type="doi">10.1002/14651858.CD003085.pub3</pub-id>, PMID: <pub-id pub-id-type="pmid">30110521</pub-id>
</mixed-citation></ref><ref id="ref6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000fc;resir</surname><given-names>E</given-names></name><name><surname>Beck</surname><given-names>J</given-names></name><name><surname>Vatter</surname><given-names>H</given-names></name><name><surname>Setzer</surname><given-names>M</given-names></name><name><surname>Gerlach</surname><given-names>R</given-names></name><name><surname>Seifert</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Subarachnoid hemorrhage and intracerebral hematoma: incidence, prognostic factors, and outcome</article-title>. <source>Neurosurgery</source>. (<year>2008</year>) <volume>63</volume>:<fpage>1088</fpage>&#x02013;<lpage>94</lpage>. doi: <pub-id pub-id-type="doi">10.1227/01.NEU.0000335170.76722.B9</pub-id><pub-id pub-id-type="pmid">19057320</pub-id>
</mixed-citation></ref><ref id="ref7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molyneux</surname><given-names>AJ</given-names></name><name><surname>Birks</surname><given-names>J</given-names></name><name><surname>Clarke</surname><given-names>A</given-names></name><name><surname>Sneade</surname><given-names>M</given-names></name><name><surname>Kerr</surname><given-names>RSC</given-names></name></person-group>. <article-title>The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT)</article-title>. <source>Lancet</source>. (<year>2015</year>) <volume>385</volume>:<fpage>691</fpage>&#x02013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(14)60975-2</pub-id>, PMID: <pub-id pub-id-type="pmid">25465111</pub-id>
</mixed-citation></ref><ref id="ref8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Ling</surname><given-names>X</given-names></name><name><surname>Petersen</surname><given-names>JD</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Xiao</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name></person-group>. <article-title>Clipping versus coiling for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of prospective studies</article-title>. <source>Neurosurg Rev</source>. (<year>2022</year>) <volume>45</volume>:<fpage>1291</fpage>&#x02013;<lpage>302</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10143-021-01704-0</pub-id>, PMID: <pub-id pub-id-type="pmid">34870768</pub-id>
</mixed-citation></ref><ref id="ref9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lou</surname><given-names>M</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Tan</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update on organizational stroke management</article-title>. <source>Stroke Vasc Neurol</source>. (<year>2020</year>) <volume>5</volume>:<fpage>260</fpage>&#x02013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1136/svn-2020-000355</pub-id>, PMID: <pub-id pub-id-type="pmid">32641444</pub-id>
</mixed-citation></ref><ref id="ref10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dekker</surname><given-names>L</given-names></name><name><surname>Venema</surname><given-names>E</given-names></name><name><surname>Pirson</surname><given-names>FAV</given-names></name><name><surname>Majoie</surname><given-names>CBLM</given-names></name><name><surname>Emmer</surname><given-names>BJ</given-names></name><name><surname>Jansen</surname><given-names>IGH</given-names></name><etal/></person-group>. <article-title>Endovascular treatment in anterior circulation stroke beyond 6.5 hours after onset or time last seen well: results from the MR CLEAN registry</article-title>. <source>Stroke Vasc Neurol</source>. (<year>2021</year>) <volume>6</volume>:<fpage>572</fpage>&#x02013;<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.1136/svn-2020-000803</pub-id>, PMID: <pub-id pub-id-type="pmid">33827915</pub-id>
</mixed-citation></ref><ref id="ref11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hop</surname><given-names>JW</given-names></name><name><surname>Rinkel</surname><given-names>GJ</given-names></name><name><surname>Algra</surname><given-names>A</given-names></name><name><surname>van Gijn</surname><given-names>J</given-names></name></person-group>. <article-title>Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review</article-title>. <source>Stroke</source>. (<year>1997</year>) <volume>28</volume>:<fpage>660</fpage>&#x02013;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1161/01.STR.28.3.660</pub-id>, PMID: <pub-id pub-id-type="pmid">9056628</pub-id>
</mixed-citation></ref><ref id="ref12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bor</surname><given-names>AS</given-names></name><name><surname>Koffijberg</surname><given-names>H</given-names></name><name><surname>Wermer</surname><given-names>MJ</given-names></name><name><surname>Rinkel</surname><given-names>GJ</given-names></name></person-group>. <article-title>Optimal screening strategy for familial intracranial aneurysms: a cost-effectiveness analysis</article-title>. <source>Neurology</source>. (<year>2010</year>) <volume>74</volume>:<fpage>1671</fpage>&#x02013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1212/WNL.0b013e3181e04297</pub-id>, PMID: <pub-id pub-id-type="pmid">20498435</pub-id>
</mixed-citation></ref><ref id="ref13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broderick</surname><given-names>JP</given-names></name><name><surname>Brown</surname><given-names>RD</given-names><suffix>Jr</suffix></name><name><surname>Sauerbeck</surname><given-names>L</given-names></name><name><surname>Hornung</surname><given-names>R</given-names></name><name><surname>Huston</surname><given-names>J</given-names><suffix>III</suffix></name><name><surname>Woo</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Greater rupture risk for familial as compared to sporadic unruptured intracranial aneurysms</article-title>. <source>Stroke</source>. (<year>2009</year>) <volume>40</volume>:<fpage>1952</fpage>&#x02013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.108.542571</pub-id>, PMID: <pub-id pub-id-type="pmid">19228834</pub-id>
</mixed-citation></ref><ref id="ref14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsson</surname><given-names>SC</given-names></name><name><surname>M&#x000e4;nnist&#x000f6;</surname><given-names>S</given-names></name><name><surname>Virtanen</surname><given-names>MJ</given-names></name><name><surname>Kontto</surname><given-names>J</given-names></name><name><surname>Albanes</surname><given-names>D</given-names></name><name><surname>Virtamo</surname><given-names>J</given-names></name></person-group>. <article-title>Dietary fiber and fiber-rich food intake in relation to risk of stroke in male smokers</article-title>. <source>Eur J Clin Nutr</source>. (<year>2009</year>) <volume>63</volume>:<fpage>1016</fpage>&#x02013;<lpage>24</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ejcn.2009.16</pub-id>, PMID: <pub-id pub-id-type="pmid">19319150</pub-id>
</mixed-citation></ref><ref id="ref15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lall</surname><given-names>RR</given-names></name><name><surname>Eddleman</surname><given-names>CS</given-names></name><name><surname>Bendok</surname><given-names>BR</given-names></name><name><surname>Batjer</surname><given-names>HH</given-names></name></person-group>. <article-title>Unruptured intracranial aneurysms and the assessment of rupture risk based on anatomical and morphological factors: sifting through the sands of data</article-title>. <source>Neurosurg Focus</source>. (<year>2009</year>) <volume>26</volume>:<fpage>E2</fpage>. doi: <pub-id pub-id-type="doi">10.3171/2009.2.FOCUS0921</pub-id>, PMID: <pub-id pub-id-type="pmid">19408998</pub-id>
</mixed-citation></ref><ref id="ref16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindner</surname><given-names>SH</given-names></name><name><surname>Bor</surname><given-names>AS</given-names></name><name><surname>Rinkel</surname><given-names>GJ</given-names></name></person-group>. <article-title>Differences in risk factors according to the site of intracranial aneurysms</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. (<year>2010</year>) <volume>81</volume>:<fpage>116</fpage>&#x02013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1136/jnnp.2008.163063</pub-id>, PMID: <pub-id pub-id-type="pmid">20019231</pub-id>
</mixed-citation></ref><ref id="ref17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linn</surname><given-names>FH</given-names></name><name><surname>Rinkel</surname><given-names>GJ</given-names></name><name><surname>Algra</surname><given-names>A</given-names></name><name><surname>van Gijn</surname><given-names>J</given-names></name></person-group>. <article-title>Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis</article-title>. <source>Stroke</source>. (<year>1996</year>) <volume>27</volume>:<fpage>625</fpage>&#x02013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1161/01.STR.27.4.625</pub-id>, PMID: <pub-id pub-id-type="pmid">8614919</pub-id>
</mixed-citation></ref><ref id="ref18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Comparative bioinformatics analysis between proteomes of rabbit aneurysm model and human intracranial aneurysm with label-free quantitative proteomics</article-title>. <source>CNS Neurosci Ther</source>. (<year>2021</year>) <volume>27</volume>:<fpage>101</fpage>&#x02013;<lpage>12</lpage>. doi: <pub-id pub-id-type="doi">10.1111/cns.13570</pub-id>, PMID: <pub-id pub-id-type="pmid">33389819</pub-id>
</mixed-citation></ref><ref id="ref19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Connolly</surname><given-names>ES</given-names><suffix>Jr</suffix></name><name><surname>Rabinstein</surname><given-names>AA</given-names></name><name><surname>Carhuapoma</surname><given-names>JR</given-names></name><name><surname>Derdeyn</surname><given-names>CP</given-names></name><name><surname>Dion</surname><given-names>J</given-names></name><name><surname>Higashida</surname><given-names>RT</given-names></name><etal/></person-group>. <article-title>Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association</article-title>. <source>Stroke</source>. (<year>2012</year>) <volume>43</volume>:<fpage>1711</fpage>&#x02013;<lpage>37</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STR.0b013e3182587839</pub-id>, PMID: <pub-id pub-id-type="pmid">22556195</pub-id>
</mixed-citation></ref><ref id="ref20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>T</given-names></name><name><surname>Juvela</surname><given-names>S</given-names></name><name><surname>Unterberg</surname><given-names>A</given-names></name><name><surname>Jung</surname><given-names>C</given-names></name><name><surname>Forsting</surname><given-names>M</given-names></name><name><surname>Rinkel</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage</article-title>. <source>Cerebrovasc Dis</source>. (<year>2013</year>) <volume>35</volume>:<fpage>93</fpage>&#x02013;<lpage>112</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000346087</pub-id>, PMID: <pub-id pub-id-type="pmid">23406828</pub-id>
</mixed-citation></ref><ref id="ref21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>H</given-names></name><name><surname>Yan</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>In-hospital complication-related risk factors for discharge and 90-day outcomes in patients with aneurysmal subarachnoid hemorrhage after surgical clipping and endovascular coiling: a propensity score-matched analysis</article-title>. <source>J Neurosurg</source>. (<year>2021</year>) <volume>137</volume>:<fpage>381</fpage>&#x02013;<lpage>92</lpage>. doi: <pub-id pub-id-type="doi">10.3171/2021.10.JNS211484</pub-id><pub-id pub-id-type="pmid">34972088</pub-id>
</mixed-citation></ref><ref id="ref22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakker</surname><given-names>NA</given-names></name><name><surname>Metzemaekers</surname><given-names>JD</given-names></name><name><surname>Groen</surname><given-names>RJ</given-names></name><name><surname>Mooij</surname><given-names>JJ</given-names></name><name><surname>Van Dijk</surname><given-names>JM</given-names></name></person-group>. <article-title>International Subarachnoid Aneurysm Trial 2009: endovascular coiling of ruptured intracranial aneurysms has no significant advantage over neurosurgical clipping</article-title>. <source>Neurosurgery</source>. (<year>2010</year>) <volume>66</volume>:<fpage>961</fpage>&#x02013;<lpage>2</lpage>. doi: <pub-id pub-id-type="doi">10.1227/01.NEU.0000368152.67151.73</pub-id>, PMID: <pub-id pub-id-type="pmid">20404700</pub-id>
</mixed-citation></ref><ref id="ref23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molyneux</surname><given-names>AJ</given-names></name><name><surname>Kerr</surname><given-names>RS</given-names></name><name><surname>Yu</surname><given-names>LM</given-names></name><name><surname>Clarke</surname><given-names>M</given-names></name><name><surname>Sneade</surname><given-names>M</given-names></name><name><surname>Yarnold</surname><given-names>JA</given-names></name><etal/></person-group>. <article-title>International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion</article-title>. <source>Lancet</source>. (<year>2005</year>) <volume>366</volume>:<fpage>809</fpage>&#x02013;<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(05)67214-5</pub-id>, PMID: <pub-id pub-id-type="pmid">16139655</pub-id>
</mixed-citation></ref><ref id="ref24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Risselada</surname><given-names>R</given-names></name><name><surname>Lingsma</surname><given-names>HF</given-names></name><name><surname>Bauer-Mehren</surname><given-names>A</given-names></name><name><surname>Friedrich</surname><given-names>CM</given-names></name><name><surname>Molyneux</surname><given-names>AJ</given-names></name><name><surname>Kerr</surname><given-names>RSC</given-names></name><etal/></person-group>. <article-title>Prediction of 60 day case-fatality after aneurysmal subarachnoid haemorrhage: results from the International Subarachnoid Aneurysm Trial (ISAT)</article-title>. <source>Eur J Epidemiol</source>. (<year>2010</year>) <volume>25</volume>:<fpage>261</fpage>&#x02013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10654-010-9432-x</pub-id>, PMID: <pub-id pub-id-type="pmid">20155439</pub-id>
</mixed-citation></ref><ref id="ref25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Dong</surname><given-names>J</given-names></name></person-group>. <article-title>A nomogram risk prediction model for poor outcome of primary brainstem hemorrhage based on clinical data and radiographic features</article-title>. <source>Neurol Sci</source>. (<year>2023</year>) <volume>44</volume>:<fpage>3967</fpage>&#x02013;<lpage>78</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10072-023-06866-x</pub-id>, PMID: <pub-id pub-id-type="pmid">37213039</pub-id>
</mixed-citation></ref><ref id="ref26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhuang</surname><given-names>D</given-names></name><name><surname>Ren</surname><given-names>Z</given-names></name><name><surname>Sheng</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Ou</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>A dynamic nomogram for predicting unfavorable prognosis after aneurysmal subarachnoid hemorrhage</article-title>. <source>Ann Clin Transl Neurol</source>. (<year>2023</year>) <volume>10</volume>:<fpage>1058</fpage>&#x02013;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.1002/acn3.51789</pub-id>, PMID: <pub-id pub-id-type="pmid">37198730</pub-id>
</mixed-citation></ref><ref id="ref27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nastasovic</surname><given-names>T</given-names></name><name><surname>Milakovic</surname><given-names>B</given-names></name><name><surname>Stosic</surname><given-names>M</given-names></name><name><surname>Eric Marinkovic</surname><given-names>J</given-names></name><name><surname>Ilic</surname><given-names>R</given-names></name><name><surname>Milicevic</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Predictors of unfavourable outcome in aneurysmal subarachnoid haemorrhage</article-title>. <source>Neurol Neurochir Pol</source>. (<year>2019</year>) <volume>53</volume>:<fpage>421</fpage>&#x02013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.5603/PJNNS.a2019.0051</pub-id><pub-id pub-id-type="pmid">31657445</pub-id>
</mixed-citation></ref><ref id="ref28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>JH</given-names></name><name><surname>Li</surname><given-names>XK</given-names></name><name><surname>Chen</surname><given-names>ZB</given-names></name><name><surname>Cai</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Ye</surname><given-names>YH</given-names></name><etal/></person-group>. <article-title>D-dimer may predict poor outcomes in patients with aneurysmal subarachnoid hemorrhage: a retrospective study</article-title>. <source>Neural Regen Res</source>. (<year>2017</year>) <volume>12</volume>:<fpage>2014</fpage>&#x02013;<lpage>20</lpage>. doi: <pub-id pub-id-type="doi">10.4103/1673-5374.221158</pub-id>, PMID: <pub-id pub-id-type="pmid">29323040</pub-id>
</mixed-citation></ref><ref id="ref29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raatikainen</surname><given-names>E</given-names></name><name><surname>Kiiski</surname><given-names>H</given-names></name><name><surname>Kuitunen</surname><given-names>A</given-names></name><name><surname>Junttila</surname><given-names>E</given-names></name><name><surname>Huhtala</surname><given-names>H</given-names></name><name><surname>Kallonen</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Increased blood coagulation is associated with poor neurological outcome in aneurysmal subarachnoid hemorrhage</article-title>. <source>J Neurol Sci</source>. (<year>2024</year>) <volume>458</volume>:<fpage>122943</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jns.2024.122943</pub-id>, PMID: <pub-id pub-id-type="pmid">38422781</pub-id>
</mixed-citation></ref><ref id="ref30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Yao</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Chong</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Association between D-dimer levels and long-term mortality in patients with aneurysmal subarachnoid hemorrhage</article-title>. <source>Neurosurg Focus</source>. (<year>2022</year>) <volume>52</volume>:<fpage>E8</fpage>. doi: <pub-id pub-id-type="doi">10.3171/2021.12.FOCUS21512</pub-id>, PMID: <pub-id pub-id-type="pmid">35231898</pub-id>
</mixed-citation></ref><ref id="ref31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Shang</surname><given-names>F</given-names></name><name><surname>Qi</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Qu</surname><given-names>X</given-names></name></person-group>. <article-title>Related factors and a threshold of the maximum neuron-specific enolase value affecting the prognosis of patients with aneurysmal subarachnoid hemorrhage</article-title>. <source>Appl Bionics Biomech</source>. (<year>2022</year>) <volume>2022</volume>:<fpage>7596426</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2022/7596426</pub-id>, PMID: <pub-id pub-id-type="pmid">35572059</pub-id>
</mixed-citation></ref></ref-list></back></article>